{"url_path":"/sec/xgn/8-k/2026-06-09/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-09","source_url":"https://www.sec.gov/Archives/edgar/data/1274737/0001274737-26-000033-index.html","accession_number":"0001274737-26-000033","cik":"0001274737","ticker":"XGN","issuer_name":"EXAGEN INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1274737/0001274737-26-000033-index.html","primary_entity_key":"0001274737","primary_entity_name":"EXAGEN INC."},"word_count":266,"has_tables":true,"body_markdown":"Item 5.07. Submission of Matters to a Vote of Security Holders.\n\nExagen Inc. (the \"Company\") held its 2026 annual meeting of stockholders (the \"Annual Meeting\") on June 9, 2026. At the Annual Meeting, the Company's stockholders voted on three proposals, as described below. Each of the proposals was described in detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 27, 2026 (the “Proxy Statement”). The vote totals noted below are final voting results from the Annual Meeting.\n\nProposal 1\n\nThe Company's stockholders elected the following two Class I directors for a three-year term of office expiring at the Company's 2029 annual meeting of stockholders and until their successors are duly elected and qualified or until such director's earlier death, resignation or removal.\n\nName\n\nVotes For\n\nVotes Withheld\n\nBroker Non-Votes\n\nTina S. Nova, Ph.D.\n8,094,349220,9548,663,346\n\nScott Kahn, Ph.D.\n6,295,8372,019,4668,663,346\n\nProposal 2\n\nThe Company's stockholders ratified the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.\n\nVotes For\n\nVotes Against\n\nAbstentions\n\nBroker Non-Votes\n\n16,955,368423,277\n__\n\nProposal 3\n\nThe Company's stockholders approved, by an advisory vote, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.\n\nVotes For\n\nVotes Against\n\nAbstentions\n\nBroker Non-Votes\n\n8,271,15622,87021,2778,663,346\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nEXAGEN INC.\n\nDate: June 9, 2026\n\nBy:\n\n/s/ Jeffrey G. Black\n\nJeffrey G. Black\n\nChief Financial Officer"}